C12Y 207/0106
N-acylmannosamine kinase
Official title: N-Acylmannosamine kinase (2.7.1.60)
C12Y207/0106 (N-acylmannosamine kinase) appears on 6 US grants and 14 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 14
- Assignees
- 4
- Inventors
- 13
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 3 |
| 2020 | 0 | 2 |
| 2021 | 2 | 2 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 2 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Genetically engineered eukaryotic cells producing sialylated glycoproteins6 Jan 2026US 12,516,361 B2Universiteit Gent
- GNE as a therapeutic agent9 Jan 2024US 11,865,165 B2
- Method for producing N-Acetyl-D-Glucosamine and/or D-Glucosamine salt by microbial fermentation11 Oct 2022US 11,466,300 B2
- Microbial fermentation method for production of n-acetyl-d-glucosamine and/or d-glucosamine salt5 Oct 2021US 11,136,608 B2
- Method for producing n-acetyl-d-glucosamine and/or d-glucosamine salt by microbial fermentation14 Sep 2021US 11,118,205 B2
- Gne as a therapeutic agent29 Aug 2024US 2024/0285734 A1
- Mouse model and treatment of hereditary inclusion body myopathy4 Jul 2024US 2024/0216405 A1Hibm Research Group, Inc.
- Bacterial system for producing human o-glycoproteins25 May 2023US 2023/0159973 A1Cornell University
- Methods and compositions for increasing sialic acid production and treating sialic related disease conditions24 Mar 2022US 2022/0088223 A1
- Mouse model and treatment of hereditary inclusion body myopathy16 Dec 2021US 2021/0386769 A1Hibm Research Group, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.